Crossref
LDL Desialylation as a Trigger of Atherogenesis: Sialidase Inhibition as a Novel Anti-atherosclerotic Strategy
Gene Expression · 30.07.2026 · 25 (3)
DOI: 10.14218/ge.2024.00062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene Expression, online erschienen am 29.07.2026. Verfasst von Veronika A. Myasoedova und 3 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Myasoedova, V. A., Orekhov, N. A., Churov, A. V., & Orekhov, A. N. (2026). LDL Desialylation as a Trigger of Atherogenesis: Sialidase Inhibition as a Novel Anti-atherosclerotic Strategy. Gene Expression, 25(3). https://doi.org/10.14218/ge.2024.00062
Vancouver
Myasoedova VA, Orekhov NA, Churov AV, Orekhov AN. LDL Desialylation as a Trigger of Atherogenesis: Sialidase Inhibition as a Novel Anti-atherosclerotic Strategy. Gene Expression. 2026;25(3). doi:10.14218/ge.2024.00062
BibTeX
@article{Myasoedova2026,
author = {Myasoedova, Veronika A. and Orekhov, Nikolay A. and Churov, Alexey V. and Orekhov, Alexander N.},
title = {LDL Desialylation as a Trigger of Atherogenesis: Sialidase Inhibition as a Novel Anti-atherosclerotic Strategy},
journal = {Gene Expression},
year = {2026},
volume = {25},
number = {3},
doi = {10.14218/ge.2024.00062}
}
EUVIMED